title: Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial.
authors.affiliation: a Oregon Health & Science University , Portland , OR , USA.
authors.forename: Alexey V
authors.initials: AV
authors.lastname: Danilov
authors.affiliation: b SWOG Statistical Center , Seattle , WA , USA.
authors.forename: Hongli
authors.initials: H
authors.lastname: Li
authors.affiliation: c Fred Hutchinson Cancer Research Center , Seattle , WA , USA.
authors.forename: Oliver W
authors.initials: OW
authors.lastname: Press
authors.affiliation: d Mount Sinai Beth Israel Medical Center , New York , NY , USA.
authors.forename: Ilan
authors.initials: I
authors.lastname: Shapira
authors.affiliation: e Johns Hopkins Cancer Center , Baltimore , MD , USA.
authors.forename: Lode J
authors.initials: LJ
authors.lastname: Swinnen
authors.affiliation: f Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College , New York , NY , USA.
authors.forename: Ariela
authors.initials: A
authors.lastname: Noy
authors.affiliation: g University of California at San Diego Moores Cancer Center , La Jolla , CA , USA.
authors.forename: Erin
authors.initials: E
authors.lastname: Reid
authors.affiliation: h University of Chicago , Chicago , IL , USA.
authors.forename: Sonali M
authors.initials: SM
authors.lastname: Smith
authors.affiliation: i University of Rochester , Rochester , NY , USA.
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Friedberg
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use; D003606:Dacarbazine / Q000009:adverse effects / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D019788:Fluorodeoxyglucose F18; D006679:HIV Seropositivity; D006689:Hodgkin Disease / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000628:therapy; D053208:Kaplan-Meier Estimate; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods; D016896:Treatment Outcome; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D001761:Bleomycin; D003606:Dacarbazine; D004317:Doxorubicin; D019788:Fluorodeoxyglucose F18; D014747:Vinblastine